Advisory Committee Vote
- The Advisory Committee on Immunization Practices (ACIP) recommended eliminating thimerosal from flu vaccines.
- The vote was unanimous despite some opposition, notably from Dr. Cody Meissner.
Safety Debate
- Critics cited risks of chronic thimerosal exposure, linking it to neurodevelopmental issues such as tics.
- The CDC removed an unapproved document that claimed no link between thimerosal and autism.
Industry Status
- 95% of 2024–2025 flu vaccines are already thimerosal-free.
- Manufacturers like Sanofi and Seqirus still produce vaccines with thimerosal.
- Implementation of the ACIP's recommendation will take time.
Political Context
- Health Secretary Robert F. Kennedy Jr. replaced all 17 ACIP members and raised concerns about cumulative mercury exposure from flu shots.
- This vote marks a move toward fully phasing out thimerosal in federally recommended vaccines.
Committee Background
- The recommendation reflects ongoing concerns about repeated exposure, especially for vulnerable groups.
- The CDC first urged the phase-out of thimerosal 25 years ago, but it remains in some flu shots.
Internal Committee Division
- Some members, including Dr. Meissner, argued there is no proof of thimerosal causing harm.
- Vicky Pebsworth abstained from voting due to insufficient discussion; Dr. Meissner was the only dissenting member.
Future Considerations
- The CDC will review the recommendation, while some manufacturers have not responded publicly.
- The vote represents a formal step towards ending thimerosal's use in CDC-recommended vaccines.
Public Concerns
- The decision reflects evolving science and public scrutiny, addressing fears related to vaccine preservative safety.
- Questions remain regarding thimerosal’s legacy and the balance between safety and vaccine access.
https://www.naturalnews.com/2025-06-30-cdc-finally-votes-remove-thimerosal-from-vaccines.html
No comments:
Post a Comment